We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$747M
AUM Growth
-$68.4M
Cap. Flow
-$45M
Cap. Flow %
-6.03%
Top 10 Hldgs %
35.25%
Holding
111
New
12
Increased
44
Reduced
34
Closed
21

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16.1M
2
PODD icon
Insulet
PODD
+$15.9M
3
ICLR icon
Icon
ICLR
+$11.6M
4
HUM icon
Humana
HUM
+$10.1M
5
BSX icon
Boston Scientific
BSX
+$9.23M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$17.4M
2
THC icon
Tenet Healthcare
THC
+$16.2M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$15.6M
4
COR icon
Cencora
COR
+$13.9M
5
OSCR icon
Oscar Health
OSCR
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.27%
2 Industrials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INZY
101
DELISTED
Inozyme Pharma
INZY
– –
-222,943
Closed -$1.71M
IRON icon
102
Disc Medicine
IRON
$3.09B
– –
-107,593
Closed -$6.7M
LAB icon
103
Standard BioTools
LAB
$312M
– –
-1,670,401
Closed -$4.53M
LYRA
104
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-12,845
Closed -$3.99M
NKTX icon
105
Nkarta
NKTX
$171M
– –
-252,028
Closed -$2.72M
NVCR icon
106
NovoCure
NVCR
$2.05B
– –
-50,000
Closed -$782K
OSCR icon
107
Oscar Health
OSCR
$9.14B
– –
-831,283
Closed -$12.4M
SOPH icon
108
SOPHiA GENETICS
SOPH
$635M
– –
-209,896
Closed -$1.03M
TMO icon
109
Thermo Fisher Scientific
TMO
$223B
– –
-15,572
Closed -$9.05M
SILK
110
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-848,897
Closed -$15.6M
DCPH
111
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-729,230
Closed -$11.5M
1 2 3 4
5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Parkman Healthcare Partners held 111 positions worth $747M, down 8.4% from $815M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners withdrew a net $45M in Q2 2024, closing 21 positions and reducing 34 holdings. Its most notable exit was Inspire Medical Systems, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Agios Pharmaceuticals worth $19.2M.

  • Parkman Healthcare Partners's largest Q2 2024 buy was Agios Pharmaceuticals: 446,416 shares worth $19.2M.
  • Parkman Healthcare Partners added most to Insulet in Q2 2024, an estimated $15.9M increase.
  • Parkman Healthcare Partners's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $16.2M.
  • Parkman Healthcare Partners fully exited Inspire Medical Systems in Q2 2024, selling an estimated $17.4M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $747M portfolio in Q2 2024.
  • Parkman Healthcare Partners opened 12 new positions and closed 21 in Q2 2024.
  • Parkman Healthcare Partners's portfolio value fell 8.4% quarter-over-quarter to $747M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.